Abstract
Clinical care in ophthalmology is rapidly evolving as artificial intelligence (AI) algorithms are being developed. The medical community and national and federal regulatory bodies are recognizing the importance of adapting to AI. However, there is a gap in physicians’ understanding of AI and its implications regarding its potential use in clinical care, and there are limited resources and established programs focused on AI and medical education in ophthalmology. Physicians are essential in the application of AI in a clinical context. An AI curriculum in ophthalmology can help provide physicians with a fund of knowledge and skills to integrate AI into their practice. In this paper, we provide general recommendations for an AI curriculum for medical students, residents, and fellows in ophthalmology.
AI and Medical Education in Ophthalmology During and Beyond the COVID-19 Pandemic
Supported by Grants from the National Institutes of Health (R01EY19474, R01EY015473, K12EY027720, and P30EY10572) and the National Science Foundation (SCH-1622679), by unrestricted departmental funding, and by a Career Development Award (JPC) from Research to Prevent Blindness. The sponsor or funding organizations had no role in the design or conduct of this research.
American Academy of Ophthalmology Task Force on Artificial Intelligence Members
Michael F. Chiang MD (Chair), National Eye Institute, National Institutes of Health, Bethesda, MD; Departments of Ophthalmology & Medical Informatics and Clinical Epidemiology, Casey Eye Institute, Oregon Health & Science University, Portland, OR.
Michael D. Abràmoff, MD, PhD, Departments of Ophthalmology and Visual Sciences, Electrical and Computer Engineering, and Biomedical Engineering, University of Iowa, Iowa City, IA; Digital Diagnostic, Inc., Coralville, IA.
J. Peter Campbell, MD, MPH, Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, OR.
Pearse A. Keane, MD, FRCOphth, Institute of Ophthalmology, University College London, UK; Medical Retina Service, Moorfields Eye Hospital NHS Foundation Trust, London, UK.
Aaron Y. Lee, MD, MSCI, Department of Ophthalmology, University of Washington, Seattle, WA.
Louis R. Pasquale, MD, Eye and Vision Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
Pietro Perona, PhD, Departments of Electrical Engineering and Computational and Neural Systems, California Institute of Technology, Pasadena, CA.
Michael X. Repka, MD, MBA, Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD.
Rishi P. Singh, MD, Center for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland Clinic, Cleveland, OH.
Daniel Ting, MD, PhD, Singapore National Eye Center, Duke-NUS Medical School, Singapore.
Staff: Flora C. Lum, MD, American Academy of Ophthalmology, San Francisco, CA.
Disclosure: N.G. Valikodath, None; E. Cole, None; D.S.W. Ting, None; J.P. Campbell, None; L.R. Pasquale, Verily (C), Eyenovia (C), Bausch + Lomb (C), Nicox (C), Emerald Bioscience (C); M.F. Chiang, None; R.V.P. Chan, Phoenix Technology (S), Alcon (C)